AMPH (Amphastar Pharmaceuticals) Future 3-5Y EPS without NRI Growth Rate : 20.82 (As of Jan. 18, 2025)

View and export this data going back to 2014. Start your Free Trial

What is Amphastar Pharmaceuticals Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Amphastar Pharmaceuticals's Future 3-5Y EPS without NRI Growth Rate is 20.82.

Competitive Comparison of Amphastar Pharmaceuticals's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amphastar Pharmaceuticals's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Amphastar Pharmaceuticals's Future 3-5Y EPS without NRI Growth Rate falls into.

Amphastar Pharmaceuticals (NAS:AMPH) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Amphastar Pharmaceuticals Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Amphastar Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (NAS:AMPH) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

29A:Germany

Address

11570 6th Street, Rancho Cucamonga, CA, USA, 91730

Website

https://www.amphastar.com

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Executives

Richard K Prins	director
Rong Zhou	officer: EVP, Production	C/O AMPHASTAR PHARMACEUTICALS INC., 11570 SIXTH STREET, RANCHO CUCAMONGA CA 91730
William J Peters	officer: CFO, SVP & Treasurer	C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Yakob Liawatidewi	officer: SVP Corp Admin Center	C/O AMPHASTAR PHARMACEUTICALS INC, 11570 SIXTH STREET, RANCHO CUCAMONGA CA 91730
Floyd F. Petersen	director	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Michael A Zasloff	director
Mary Z. Luo	director, 10 percent owner, officer: COO and Chief Scientist	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Gayle Deflin	director	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Diane G. Gerst	officer: EVP, QA & Regulatory Affairs	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Howard Lee	director	13F-2, NO. 36, LANE 48, SECTION 3, NAN-JING EAST ROAD, TAIPEI, TAIWAN F4 00000
Jack Y. Zhang	director, 10 percent owner, officer: CEO & Chief Scientific Officer	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
David Maris	director	C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Richard Koo	director	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Jason B. Shandell	director, officer: President	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Applied Physics & Chemistry Laboratories, Inc.	10 percent owner	13760 MAGNOLIA AVENUE, CHINO CA 91710